showdown clash versus vs crash lightning fight dispute
Pharma

The Oral GLP-1 Tracker: Lilly’s Foundayo launch remains ‘muted’

Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
checkered flag finish line racecar

FDA expands Padcev-Keytruda combo to more MIBC patients

Jul 10, 2026 1:10pm
Bayer

Bayer scores €3B capital equity infusion in deal with Apollo

Jul 10, 2026 11:31am
Thumbnail from BioMarins PKU podcast

Young people with PKU take the mic in BioMarin podcast series

Jul 10, 2026 11:28am
FDA stop sign

FDA rejects Hengrui, Elevar PD-1 liver cancer combo a 3rd time

Jul 10, 2026 10:55am
Magnifying glass with pills on blue

Regulatory tracker: NICE shoots down Lumakras reimbursement

Jul 10, 2026 10:21am
More News

After FDA delay, Sanofi scores subcutaneous OBI nod for Sarclisa

Jul 10, 2026 9:18am

A $10B deal, China trial scrutiny and highlights from ADA 2026

Jul 10, 2026 9:18am

AZ's China deals, Kailera-Hengrui—Fierce Pharma Asia

Jul 10, 2026 8:51am

Sobi tops bleeding disorder patient groups' reputation rankings

Jul 9, 2026 6:06pm